News & Updates

Show Multimedia Only

Mepolizumab does little to improve dysphagia symptoms

17 Jul 2023

Mepolizumab does not appear to reduce the symptoms of dysphagia as compared with placebo in the treatment of individuals with eosinophilic oesophagitis (EoE), although the drug helps reduce eosinophil counts and endoscopic severity, according to a study.

17 Jul 2023

Fewer migraine days with dual therapy

17 Jul 2023 by

Combination therapy with an anti-CGRP* monoclonal antibody (mAB) and onabotulinumtoxinA may be more effective than either therapy in patients with chronic migraine, according to a new study.

17 Jul 2023

Bezlotoxumab prevents CDI recurrence in immunocompromised patients

16 Jul 2023

Treatment with bezlotoxumab results in a significant decrease in recurrent Clostridioides difficile infection (CDI) in a cohort of immunocompromised patients and transplant recipients, reports a study.

16 Jul 2023

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

15 Jul 2023

Time to recovery from COVID-19 pneumonia does not appear to differ following treatment with abatacept, cenicriviroc, or infliximab among hospitalized patients, according to a study.

15 Jul 2023

Danuglipron helps with glucose control, weight loss in T2D

15 Jul 2023 by

The glucagon-like peptide 1 receptor (GLP-1R) agonist danuglipron appears to be beneficial in the treatment of patients with type 2 diabetes (T2D), yielding reductions in glycated haemoglobin (HbA1c), fasting plasma glucose (FPG), and body weight, without fasting restrictions, as shown in the results of a phase IIb study.

15 Jul 2023

Long-acting ART induces viral suppression in people with HIV

15 Jul 2023

People with HIV (PWH) who are treated with long-acting (LA) antiretroviral therapy (ART) achieve virologic suppression, as do those with viraemia and challenges to adherence, reports a study.

15 Jul 2023

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

14 Jul 2023

Perioperative tranexamic acid treatment in patients undergoing holmium laser enucleation of the prostate (HoLEP) falls short of reducing the risk of a return to the operating room for bleeding, catheter reinsertion, or clotting complications, according to a study.

14 Jul 2023

Patient preferences must be considered for anticoagulation duration in unprovoked VTE

14 Jul 2023

Shared decision making should be practiced by clinicians to include patient preferences and values when taking into account the duration of anticoagulant therapy for unprovoked venous thromboembolism (VTE), suggests a study.

14 Jul 2023

Ustekinumab shows efficacy in Asians with plaque psoriasis

14 Jul 2023 by

Asian patients with moderate to severe plaque psoriasis may benefit from ustekinumab therapy, which has been shown to be both safe and effective in a Singapore study.

14 Jul 2023

Fitusiran cuts bleeding in haemophilia patients regardless of inhibitor use

14 Jul 2023 by

In the phase III ATLAS-PPX trial, the investigational siRNA* therapeutic fitusiran significantly cut bleeding events compared with factor/bypassing agent (BPA) prophylaxis in patients with haemophilia A or B with or without inhibitors.

14 Jul 2023

News & Updates

Showing Pharmacy articles

Showing

Specialty:

Mepolizumab does little to improve dysphagia symptoms

Fewer migraine days with dual therapy

Bezlotoxumab prevents CDI recurrence in immunocompromised patients

Time to recovery from COVID-19 pneumonia similar for abatacept, cenicriviroc, infliximab

Danuglipron helps with glucose control, weight loss in T2D

Long-acting ART induces viral suppression in people with HIV

Tranexamic acid of no help in reducing bleeding complications related to HoLEP

Patient preferences must be considered for anticoagulation duration in unprovoked VTE

Ustekinumab shows efficacy in Asians with plaque psoriasis

Fitusiran cuts bleeding in haemophilia patients regardless of inhibitor use